128 related articles for article (PubMed ID: 8299527)
21. Angiotensin-converting enzyme inhibition and the combination of a beta blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis.
Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1993; 8(9):808-13. PubMed ID: 8255512
[TBL] [Abstract][Full Text] [Related]
22. Once daily lisinopril and captopril in hypertension: a double blind comparison using ambulatory monitoring.
Mann S; O'Brien KP
N Z Med J; 1994 Oct; 107(987):391-4. PubMed ID: 7936476
[TBL] [Abstract][Full Text] [Related]
23. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
Matsuda H; Hayashi K; Saruta T
J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
[TBL] [Abstract][Full Text] [Related]
24. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH
Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585
[TBL] [Abstract][Full Text] [Related]
26. Effect of captopril on heavy proteinuria in patients with various glomerular diseases.
Han DS; Ha SK; Choi KH; Lee HY
Yonsei Med J; 1992 Sep; 33(3):232-9. PubMed ID: 1292247
[TBL] [Abstract][Full Text] [Related]
27. Effect of captopril on heavy proteinuria in azotemic diabetics.
Taguma Y; Kitamoto Y; Futaki G; Ueda H; Monma H; Ishizaki M; Takahashi H; Sekino H; Sasaki Y
N Engl J Med; 1985 Dec; 313(26):1617-20. PubMed ID: 3906398
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats.
Krishan P; Sharma A; Singh M
Pharmacol Res; 1998 Jan; 37(1):23-9. PubMed ID: 9503476
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
Aminorroaya A; Janghorbani M; Rezvanian H; Aminian T; Gharavi M; Amini M
Nephron Clin Pract; 2005; 99(3):c73-7. PubMed ID: 15665549
[TBL] [Abstract][Full Text] [Related]
30. [The use of angiotensin-converting enzyme inhibitors in patients with chronic glomerulonephritis].
Dudar IO
Lik Sprava; 1999; (7-8):55-9. PubMed ID: 10672690
[TBL] [Abstract][Full Text] [Related]
31. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
Praga M; Paz Artal E; Hernández E; Segura J; Moreno MA; Morales JM; Rodicio JL
Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
[TBL] [Abstract][Full Text] [Related]
32. Proximal renal tubular peptide catabolism, ammonia excretion and tubular injury in patients with proteinuria: before and after lisinopril.
Rustom R; Grime JS; Costigan M; Maltby P; Hughes A; Shenkin A; Critchley M; Bone JM
Clin Sci (Lond); 1998 Apr; 94(4):425-30. PubMed ID: 9640348
[TBL] [Abstract][Full Text] [Related]
33. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.
Doorenbos CR; de Cuba MM; Vogt L; Kema IP; van den Born J; Gans RO; Navis G; de Borst MH
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):56-61. PubMed ID: 21958677
[TBL] [Abstract][Full Text] [Related]
34. Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
Morisco C; Condorelli M; Crepaldi G; Rizzon P; Zardini P; Villa G; Argenziano L; Trimarco B
Cardiovasc Drugs Ther; 1997 Mar; 11(1):63-9. PubMed ID: 9140680
[TBL] [Abstract][Full Text] [Related]
35. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria.
Ruilope LM; Miranda B; Oliet A; Millet VG; Rodicio JL; Romero JC; Raij L
J Hypertens Suppl; 1988 Dec; 6(4):S467-9. PubMed ID: 3071587
[TBL] [Abstract][Full Text] [Related]
36. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy.
Huissoon AP; Meehan S; Keogh JA
Ir J Med Sci; 1991 Oct; 160(10):319-21. PubMed ID: 1810899
[TBL] [Abstract][Full Text] [Related]
37. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
[TBL] [Abstract][Full Text] [Related]
38. Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome.
Reichert LJ; Koene RA; Wetzels JF
Nephrol Dial Transplant; 1999 Jan; 14(1):91-7. PubMed ID: 10052484
[TBL] [Abstract][Full Text] [Related]
39. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function.
Fabbri A; Cocchi R; Degli Esposti E; Lucatello A; Sturani A; Tampieri G; Fusaroli M
Nephrol Dial Transplant; 1990; 5 Suppl 1():81-3. PubMed ID: 2129469
[TBL] [Abstract][Full Text] [Related]
40. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
Heeg JE; de Jong PE; de Zeeuw D
Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
